Acute Myeloid Leukemia Fought With New AI Tool
Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an assistant research professor in bioengineering at Northeastern University, says that AML also has a high recurrence rate and no one-size-fits-all treatment option. Because AML impacts both blood and bone marrow, oncologists need samples of … Read more